This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
coronavirus: Archive
Bull of the Day: Exact Sciences (EXAS)
by Kevin Cook
EPS surprises abound as Cologuard and Precision Oncology grow sales 20% into next year
EXASPositive Net Change ADPTPositive Net Change NVTAPositive Net Change NTRANegative Net Change GHPositive Net Change
cancer coronavirus genetics genomics
Bear of the Day: Inovio Pharmaceuticals (INO)
by Madeleine Johnson
Is it too late to buy this coronavirus vaccine stock?
PFENegative Net Change MRNANegative Net Change INONegative Net Change ACADPositive Net Change
coronavirus medical pharmaceuticals
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Estimates get slashed another 30% since their Q1 report, driving yoy projections negative into 2022
QDELNo Net Change
coronavirus medical
Bull Of The Day: Facebook (FB)
by Daniel Laboe
Facebook (FB), the world's most powerful social media platform, is a more attractive investment today than ever before
FBPositive Net Change
advertising coronavirus earnings media tech-stocks
Bull of the Day: National Vision (EYE)
by Kevin Cook
As a nation, optical care needs are rising and re-opening trends are spurring a big catch-up on exams
EYENegative Net Change
coronavirus medical
Bear of the Day: Clorox (CLX)
by Tracey Ryniec
Rising costs are a problem for this former pandemic winner.
CLXNegative Net Change
consumer-discretionary consumer-staples coronavirus
Bear of the Day: Quidel (QDEL)
by Kevin Cook
Rising star in diagnostics had a shot at big cap status with 200% growth on COVID testing that faded
QDELNo Net Change
coronavirus medical
Best Biotech Stocks & ETFs for mRNA, Gene Editing
by Neena Mishra
Here is what you should know about investing in these life changing technologies.
PFENegative Net Change MRNANegative Net Change TBIOPositive Net Change IBBPositive Net Change CNCRPositive Net Change EDITPositive Net Change XBIPositive Net Change CRSPNegative Net Change CHNAPositive Net Change BNTXNegative Net Change CVACNo Net Change
biotechs coronavirus
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Delay in FDA approval for latest COVID test hasn't altered growth or value at 3X sales
VIVONegative Net Change HOLXPositive Net Change NVAXNegative Net Change QDELNo Net Change
biotechs coronavirus medical
One Year Later: Lessons from the Coronavirus Stock Sell-Off
by Tracey Ryniec
What did you do with your investment portfolio when the coronavirus crisis hit in spring of 2020?
PAGPositive Net Change TMPositive Net Change ECNegative Net Change TRTNPositive Net Change PINSPositive Net Change
coronavirus stock-performance stock-price-movement value-stocks
5 Hot Upcoming Earnings Charts
by Tracey Ryniec
Earnings season is winding down over the next 2 weeks but there are still incredible earnings charts still to come.
CTASPositive Net Change ULTAPositive Net Change JDPositive Net Change DOCUPositive Net Change STNEPositive Net Change
coronavirus earnings
Vaccine Miracles: Does JNJ Kill the Profit Path for MRNA and NVAX?
by Kevin Cook
New vaccine entrant gets approval before Novavax, while herd immunity ideas put sales in doubt.
JNJNegative Net Change MRNANegative Net Change NVAXNegative Net Change
biotechs coronavirus pharmaceuticals
5 Pandemic Winner Earnings Charts
by Tracey Ryniec
These 5 companies were beneficiaries of the pandemic economy. But what happens next?
NVDAPositive Net Change MRNANegative Net Change ETSYPositive Net Change SQPositive Net Change ABNBPositive Net Change
coronavirus earnings
Hedge Fund Diaries: Who Was Buying Your Stocks?
by Kevin Cook
SEC 13Fs reveal trades from months ago, but also patterns of long-term bullish behavior.
MRNANegative Net Change GMENegative Net Change NVAXNegative Net Change SHOPPositive Net Change VXRTPositive Net Change BIGCPositive Net Change
coronavirus economy stock-performance
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 30%+ to over $335 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXPositive Net Change QDELNo Net Change
coronavirus medical
Bear Of The Day: Chico's (CHS)
by Daniel Laboe
This stock is trading far above the most optimistic price targets and I would liquidate any positions that I had in CHS, thanking god that I was able to get such a good price for them
CHSPositive Net Change
apparel coronavirus retail
Biotech Bonanza: COVID Launches Science at Warp Speed
by Kevin Cook
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
HOLXPositive Net Change MRNANegative Net Change VIVONegative Net Change NVAXNegative Net Change AXSMPositive Net Change AVXLPositive Net Change VXRTPositive Net Change SAVAPositive Net Change
biotechs coronavirus pharmaceuticals
Bear of the Day: Illumina (ILMN)
by Kevin Cook
Maker of premier next-gen genomic sequencing technology lowers guidance but shares make new highs
ILMNPositive Net Change EDITPositive Net Change NVTAPositive Net Change ARKKPositive Net Change ARKGPositive Net Change
biotechs coronavirus genetics genomics
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
VIVONegative Net Change HOLXPositive Net Change QDELNo Net Change EDITPositive Net Change CRSPNegative Net Change
coronavirus genetics genomics medical
With Vaccine Distribution, What Stocks Do I Buy?
by John Blank
A Forward Looking Market Can Be Beguiling.
GSPositive Net Change SCHWPositive Net Change QDELNo Net Change
biotechs coronavirus
Moderna Vaccine: The Power of mRNA Technology
by Kevin Cook
Warp speed was just the ticket to launch top COVID-19 vaccines -- and a revolution in medicine
AZNPositive Net Change PFENegative Net Change MRNANegative Net Change IBBPositive Net Change XBIPositive Net Change
biotechs coronavirus
Bull of the Day: Quidel (QDEL)
by Kevin Cook
COVID and influenza A+B tests have launched sales and profit estimates triple-digits into 2021
QDELNo Net Change PFENegative Net Change MRNANegative Net Change
biotechs coronavirus medical
Bear Of The Day: Royal Caribbean Cruises (RCL)
by Daniel Laboe
It is time to consider pulling profits from this frothy cruise line stock
CCLPositive Net Change RCLPositive Net Change
coronavirus travel-leisure
Stocks: Overvalued or Cheap Heading Into 2021?
by Tracey Ryniec
S&P 500 earnings are expected to rise 21% in 2021 and that may be too conservative as the coronavirus vaccine rolls out.
INTCPositive Net Change AAPLPositive Net Change SEPositive Net Change SLYPositive Net Change DOCUPositive Net Change
coronavirus stock-performance
IPO Week For DASH & ABNB
by Daniel Laboe
Christmas is coming early for two well-timed IPO's from digitally driven market leaders Airbnb and DoorDash
TSLAPositive Net Change
coronavirus e-commerce internet-content tech-stocks travel-leisure